Malassezia furfur infections. 1991

O Teglia, and P E Schoch, and B A Cunha
Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008290 Malassezia A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur (Pityrosporum orbiculare) causes TINEA VERSICOLOR. Pityrosporum,Pityrosporum ovale,Saccharomyces ovalis,Malassezia furfur,Pityrosporum orbiculare
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D003881 Dermatomycoses Superficial infections of the skin or its appendages by any of various fungi. Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

O Teglia, and P E Schoch, and B A Cunha
March 1989, Infectious disease clinics of North America,
O Teglia, and P E Schoch, and B A Cunha
August 1985, Human pathology,
O Teglia, and P E Schoch, and B A Cunha
February 1996, Archives of dermatology,
O Teglia, and P E Schoch, and B A Cunha
April 1977, Canadian journal of microbiology,
O Teglia, and P E Schoch, and B A Cunha
November 2014, Journal of medical microbiology,
O Teglia, and P E Schoch, and B A Cunha
September 1999, Revista iberoamericana de micologia,
O Teglia, and P E Schoch, and B A Cunha
July 1993, Ugeskrift for laeger,
O Teglia, and P E Schoch, and B A Cunha
October 1987, Clinical pediatrics,
O Teglia, and P E Schoch, and B A Cunha
January 1999, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!